| Albuminurie : een vroeg alarm! |
|
| Hemodialysis-induced left ventricular dysfunction : identification of prevalence, triggers, and prognostic impact |
|
| Isolated microalbuminuria indicates a poor medical prognosis |
|
| The kidney, a cardiovascular risk marker, and a new target for therapy |
|
| Klinische nefrologie |
|
| Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects |
|
| Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients |
|
| Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts |
|
| Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength? |
|
| Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening |
|
| Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study |
|
| Membrane biocompatibility does not affect whole body protein metabolism during dialysis |
|
| The metabolic response to ingested protein is normal in long-term hemodialysis patients |
|
| Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. |
|
| Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes |
|
| N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population. |
|
| Novel aspects regarding mechanisms and consequences of albuminuria |
|
| Past Decline Versus Current eGFR and Subsequent Mortality Risk |
|
| Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality |
|
| Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making |
|
| Pharmacy data in epidemiological studies: an easy to obtain and reliable tool |
|
| Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome |
|
| Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands |
|
| The power of clinician-expressed empathy to increase information recall in advanced breast cancer care: an observational study in clinical care, exploring the mediating role of anxiety |
|
| Prevention of chronic kidney disease: the next step forward! |
|
| [The prevention of renal failure has to improve]. |
|
| Prolonged frozen storage of urine reduces the value of albuminuria for mortality prediction |
|
| Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients |
|
| Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease |
|
| The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis |
|
| Relation of electrocardiographic abnormalities to levels of serum C-reactive protein |
|
| Relative blood volume changes underestimate total blood volume changes during hemodialysis |
|
| Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy |
|
| Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes |
|
| Renoprotective therapy: is it blood pressure or albuminuria that matters? |
|
| Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients |
|
| The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population. |
|
| Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. |
|
| Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands |
|
| Screening for early chronic kidney disease--what method fits best? |
|
| Screening for elevated albuminuria and subsequently hypertension identifies subjects in which treatment may be warranted to prevent renal function decline |
|
| Screening, monitoring, and treatment of albuminuria: Public health perspectives |
|
| Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors |
|
| Short-term change in kidney function and risk of end-stage renal disease |
|
| Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. |
|
| Sickle cell nephropathy : new insights into its pathophysiology |
|
| Simplified models for dark matter searches at the LHC |
|
| Social participation and employment status after kidney transplantation: a systematic review |
|
| Sodium status and angiotensin-converting enzyme inhibition: effects on plasma angiotensin-(1-7) in healthy man. |
|
| Some Patients Are More Equal Than Others: Variation in Ventilator Settings for Coronavirus Disease 2019 Acute Respiratory Distress Syndrome |
|
| Targeting of doxorubicin to the urinary bladder of the rat shows increased cytotoxicity in the bladder urine combined with an absence of renal toxicity |
|
| Time spent on documenting quality indicator data and associations between the perceived burden of documenting these data and joy in work among professionals in intensive care units in the Netherlands: a multicentre cross-sectional survey |
|
| Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future? |
|
| Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations |
|
| Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. |
|
| Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study |
|
| Validation of insulin resistance indexes in a stable renal transplant population. |
|
| The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population |
|
| Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients. |
|
| Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake? |
|
| Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment |
|
| Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis |
|
| Voordrachten gehouden in het kader van de 9e Groninger internistencursus |
|
| What predicts progression and regression of urinary albumin excretion in the nondiabetic population? |
|
| What to measure-albuminuria or total proteinuria? |
|
| Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. |
|
| Why does elevated plasma homocysteine result in severe microvascular injury, but not glomerular damage? |
|
Preferred Forms
